Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Pharmacokinetic Study of a Single-Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode

Study:

An Open-Label Study to Determine the Pharmacokinetics of a Single Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode for Which Acute Treatment With a Benzodiazepine is Clinically Indicated

Rationale:

n/a

Purpose:

The purpose of this study is to determine the pharmacokinetics of DZNS following a single dose in epileptic patients experiencing a seizure episode.

Study Status: Not yet recruiting

Recruiting:
n/a

Condition Intervention Phase
Epilepsy Drug: Diazepam Phase 2

Verified by Neuronex, Inc. August, 2011

Sponsored by: Neuronex, Inc.
Information provided by: Neuronex, Inc.
ClinicalTrials.gov identifier: NCT01417078

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

David P Ward, MD., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site